FDA NDC Directory · JSON-LD · Markdown

GIVLAARI

NDC 71336-1001 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namegivosiran sodium
Labeler / ManufacturerAlnylam Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA212194
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsGIVOSIRAN SODIUM (189 mg/mL)
Marketing started20191212
Package count1

External sources

Source: openFDA. Public-domain (CC0).